Pulmicort and Activated partial thromboplastin time prolonged - a phase IV clinical study of FDA data

Summary:

Activated partial thromboplastin time prolonged is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are female, 50-59 old, also take Xopenex, and have High blood pressure.

The phase IV clinical study analyzes which people have Activated partial thromboplastin time prolonged when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Activated partial thromboplastin time prolonged?

Activated partial thromboplastin time prolonged is found to be associated with 762 drugs and 1,209 conditions by eHealthMe. Check the latest studies of Activated partial thromboplastin time prolonged.

On Jul, 13, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 19 people (0.05%) have Activated partial thromboplastin time prolonged.

Could Pulmicort cause Activated partial thromboplastin time prolonged?

Among these 19 people:

What is the gender of people who have Activated partial thromboplastin time prolonged when taking Pulmicort? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Activated partial thromboplastin time prolonged when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Activated partial thromboplastin time prolonged? *

Hypokalemia (low potassium): 6 people, 31.58%
Lung Disorder (lung disease): 5 people, 26.32%
Cardiac Disorder: 5 people, 26.32%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 5 people, 26.32%
Hyperkalemia (damage to or disease of the kidney): 5 people, 26.32%
Drug Exposure During Pregnancy: 5 people, 26.32%
Skin Discoloration - Bluish (bluish colour of skin): 5 people, 26.32%
Disease Complication: 5 people, 26.32%
Cardiac Murmur (an heart sound in valve abnormality): 5 people, 26.32%
Cardiac Failure Congestive: 5 people, 26.32%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 15.79%
Stress And Anxiety: 2 people, 10.53%
Chromosome Abnormality (abnormal gene structure pattern): 2 people, 10.53%
Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 1 person, 5.26%
Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 5.26%
Prostate Cancer: 1 person, 5.26%
Pain: 1 person, 5.26%
Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 5.26%
Hypersensitivity: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Activated partial thromboplastin time prolonged?

- Check whether Activated partial thromboplastin time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Activated partial thromboplastin time prolonged treatments and more:

Activated partial thromboplastin time prolonged (8,799 reports)

How severe was Activated partial thromboplastin time prolonged and when was it recovered:

Activated partial thromboplastin time prolonged in Pulmicort

Expand to all the drugs that have ingredients of budesonide:

Activated partial thromboplastin time prolonged and drugs with ingredients of budesonide (46 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (762 drugs)

Browse all the conditions that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (1,209 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.